Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study

BACKGROUND: We aimed to provide real-world evidence on the benefit of persistence with antiplatelet therapy (APT) on long-term all-cause mortality (ACM) in ischemic stroke patients aged 75 years and older. METHODS: Newly diagnosed ischemic stroke patients aged 75 years and older who initiated aspiri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seung Jae, Kwon, Oh Deog, Choi, Ho Chun, Lee, Eung-Joon, Cho, BeLong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028245/
https://www.ncbi.nlm.nih.gov/pubmed/33827445
http://dx.doi.org/10.1186/s12877-021-02171-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028245/
https://www.ncbi.nlm.nih.gov/pubmed/33827445
http://dx.doi.org/10.1186/s12877-021-02171-4

Ejemplares similares